For research purposes only. Not intended for human or veterinary use. Always follow applicable regulations when handling research compounds.
What Is KLOW?
KLOW is a four-component research peptide blend developed for controlled laboratory studies involving cellular repair signaling, tissue response pathways, inflammatory signaling modulation, and extracellular matrix research. It combines BPC-157, TB-500, GHK-Cu, and KPV — four independently studied peptides — into a single laboratory-use formulation.
KLOW builds on the GLOW blend by adding KPV, a tripeptide fragment of α-MSH studied for its role in inflammatory signaling and epithelial barrier activity, making it a broader multi-pathway research tool.
What's Inside KLOW?
BPC-157
BPC-157 is a synthetic pentadecapeptide commonly studied for its interaction with angiogenic signaling, fibroblast activity, and cellular migration behavior in controlled laboratory models. Experimental research frequently examines its role in vascular signaling and localized tissue-response activity.
TB-500
TB-500 is a synthetic peptide fragment associated with thymosin beta-4 research. It is commonly utilized in laboratory environments examining cellular movement, actin regulation, tissue remodeling pathways, and systemic repair-related signaling behavior.
GHK-Cu
GHK-Cu is a copper-binding peptide complex widely studied for its interaction with collagen synthesis signaling, extracellular matrix communication, fibroblast activation pathways, and tissue-structure support mechanisms. Research models frequently evaluate GHK-Cu in studies involving skin-related signaling and regenerative communication pathways.
KPV
KPV is a short tripeptide fragment derived from alpha-melanocyte stimulating hormone (α-MSH). It is commonly examined in experimental settings involving inflammatory signaling pathways, immune-response communication, epithelial barrier activity, and cytokine-response behavior — making it the key differentiator between KLOW and GLOW.
Key Research Areas for KLOW
- Cellular repair signaling analysis
- Tissue remodeling pathway evaluation
- Extracellular matrix communication studies
- Collagen-support pathway observation
- Inflammatory signaling and cytokine-response research
- Fibroblast activation studies
- Cellular migration and angiogenic pathway evaluation
- Gut-barrier and epithelial signaling models
All findings referenced here are from preclinical or in vitro research. KLOW is not approved for therapeutic use in humans or animals.
KLOW vs. GLOW: What's the Difference?
Both KLOW and GLOW share the same BPC-157, TB-500, and GHK-Cu foundation. KLOW adds KPV, extending the blend's research scope to include inflammatory signaling pathways and epithelial barrier activity. Researchers selecting between the two typically base their choice on whether their study protocol requires KPV's specific signaling profile.
Reconstitution Guide
KLOW is supplied as a lyophilized (freeze-dried) powder blend and must be reconstituted prior to research use. Use bacteriostatic water (BW) for reconstitution.
- Allow the vial to reach room temperature before handling.
- Draw the appropriate volume of bacteriostatic water into a U-100 insulin syringe or research-grade syringe.
- Inject the water slowly along the inner wall of the vial — avoid injecting directly onto the powder.
- Gently swirl until fully dissolved. The solution should be clear and colorless.
- Label the vial with the reconstitution date and resulting concentration.
Storage Best Practices
- Lyophilized: Store at -20°C in a sealed, desiccated environment.
- Reconstituted: Refrigerate at 2–8°C and use within 28–30 days. Avoid freeze-thaw cycles.
- Light: Keep away from direct light exposure.
- Sterility: Always use sterile technique when drawing from the vial.
Get KLOW for Your Research
Frontline Peptides carries KLOW peptide blend for qualified researchers. Veteran-owned and committed to research-grade quality — no hype, just science.
Disclaimer: This article is intended for informational and educational purposes for licensed researchers only. Frontline Peptides does not condone the use of research peptides in humans or animals outside of approved research protocols.